In Vitro Activity of Ceftaroline Against Multidrug-Resistant Staphylococcus aureus and Streptococcus pneumoniae: A Review of Published Studies and the AWARE Surveillance Program (2008–2010)

Multistep Resistance Development Studies of Ceftaroline in Gram-Positive and -Negative Bacteria

(2011) Catherine Clark et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

LEADER Program Results for 2009: an Activity and Spectrum Analysis of Linezolid Using 6,414 Clinical Isolates from 56 Medical Centers in the United States

(2011) David J. Farrell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ceftaroline against Gram-Positive and Gram-Negative Pathogens Isolated from Patients in Canadian Hospitals in 2009

(2011) James A. Karlowsky et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

(2011) John S. Bradley et al.   CLINICAL INFECTIOUS DISEASES

Ceftaroline: a comprehensive update

(2011) Darpan Kaushik et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Affinity of Ceftaroline and Other  -Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae

(2010) K. Kosowska-Shick et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States

(2010) M. R. Jacobs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998–2009)

(2010) Ronald N. Jones et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia

(2010) Ronald N. Jones et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) M. H. Wilcox et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae

(2010) H. Moisan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia

(2009) Ian Morrissey et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology

(2009) F. C. Tenover et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The changing epidemiology of resistance

(2009) P. M. Hawkey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008

(2009) S. N. Patel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Increased US Emergency Department Visits for Skin and Soft Tissue Infections, and Changes in Antibiotic Choices, During the Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus

(2008) Daniel J. Pallin et al.   ANNALS OF EMERGENCY MEDICINE

In Vitro Evaluation of the Antimicrobial Activity of Ceftaroline against Cephalosporin-Resistant Isolates of Streptococcus pneumoniae

(2008) L. McGee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime

(2008) A. Fenoll et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antimicrobial Activity of a New Cephalosporin, Ceftaroline, and Determination of Quality Control Ranges for MIC Testing

(2008) S. D. Brown et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States

(2008) Y. Ge et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

National Trends in Ambulatory Visits and Antibiotic Prescribing for Skin and Soft-Tissue Infections

(2008) Adam L. Hersh   ARCHIVES OF INTERNAL MEDICINE

Executive Summary: Workshop on Issues in the Design and Conduct of Clinical Trials of Antibacterial Drugs in the Treatment of Community‐Acquired Pneumonia

(2008) Brad Spellberg et al.   CLINICAL INFECTIOUS DISEASES

Are Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Replacing Traditional Nosocomial MRSA Strains?

(2008) K. J. Popovich et al.   CLINICAL INFECTIOUS DISEASES

Emergence ofStreptococcus pneumoniaeSerotypes 19A, 6C, and 22F and Serogroup 15 in Cleveland, Ohio, in Relation to Introduction of the Protein‐Conjugated Pneumococcal Vaccine

(2008) Michael R. Jacobs et al.   CLINICAL INFECTIOUS DISEASES